7-ethyl-10-hydroxycamptothecin Completed Phase 1 Trials for Malignancies Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00542958Study of NK012 in Patients With Refractory Solid Tumors